Clinical trial screening questions for seniors and families in Los Angeles. Educational navigation only; study details must be confirmed by the research team.
Potential Compensation
Study Duration
Study Location
Memory changes can be stressful for seniors and families. Alzheimer’s and memory-related clinical trials may help researchers study screening tools, monitoring methods, investigational treatments, or care approaches for people with memory concerns or mild cognitive changes.
All Seniors Foundation can help you ask about current Alzheimer’s clinical trial screening and prepare questions before speaking with a research team. Screening does not guarantee enrollment or benefit. Formal eligibility, study availability, visit requirements, and any compensation must be confirmed by the study team during informed consent.
A coordinator may ask about memory concerns, daily function, medications, prior diagnoses, imaging history, and whether a family member or trusted support person can participate as a study partner. Some studies require memory testing, questionnaires, blood work, MRI or other imaging, medication review, and recurring study visits.
Families should ask how the study handles privacy, transportation, caregiver involvement, possible side effects, and communication with the participant’s personal healthcare providers.
We can help you prepare a medication list, write down memory concerns, identify a study partner, and organize questions for the screening call. We encourage families to involve the senior’s primary doctor, neurologist, or memory-care clinician before making a decision about research participation.
Before asking about Alzheimer’s or memory-related clinical trial screening, it helps to write down when memory changes began, what daily tasks have become harder, which medications are being used, and whether a primary doctor, neurologist, or memory specialist has already evaluated the concern. If possible, identify a trusted family member or support person who can join the call and help track questions.
Many memory studies ask about a study partner because the research team may need someone who knows the participant well, can attend visits, and can share observations over time. Asking about this requirement early helps families understand the time commitment before moving forward.
If a formal screening visit is offered, ask what records to bring, whether imaging or memory testing is required, how privacy is handled, and how results are shared. Families should also ask what happens if the senior does not qualify, because the study team may be able to explain other research options or suggest follow-up questions for the participant’s own clinician.
For general research education, review the ClinicalTrials.gov guide to clinical studies and the NIH Clinical Research Trials and You resource. These explain informed consent, participant protections, possible risks, and possible benefits.
Call All Seniors Foundation or submit the screening inquiry form to ask whether Alzheimer’s clinical trial screening is currently available. A conversation can help you understand the next step before making any commitment.
A screening call helps you understand the study, possible time commitment, informed consent process, and whether the research team may be a fit for your situation.
Some studies may provide compensation for completed study visits, travel, or time, depending on the protocol and eligibility.
Study-related visits are reviewed by trained research staff, with screening steps designed to protect participant safety.
Volunteers help researchers answer important health questions that may improve care options in the future.
A coordinator can explain what is required before you decide whether to continue with formal screening.
You can ask questions about visits, risks, possible benefits, privacy, and what participation would involve.
Participation is voluntary, and the research team should explain consent, withdrawal, and next steps before enrollment.
These points are only a starting guide. Final eligibility, availability, and enrollment decisions are confirmed by the study team.
Study openings, screening windows, and eligibility requirements can change.
No-obligation inquiry. Participation is voluntary and depends on formal screening.
Get answers to common questions before deciding whether to ask about formal screening
Not always. Some studies screen people with mild memory concerns or mild cognitive impairment. The research team confirms the exact criteria for each study.
Memory studies often ask for a trusted person who can attend key visits, help with reminders, and share observations. Requirements vary by study.
Depending on the protocol, screening may include memory assessments, questionnaires, blood work, medication review, MRI, or other imaging. The study team should explain each step.
Not necessarily. Some studies use randomization or placebo controls. The informed consent process should explain how assignment works.
Yes. Participation is voluntary. The consent materials should explain how withdrawal works and who to contact with concerns.
Clinical research should be reviewed, explained clearly, and built around informed consent, privacy, and participant choice.
Drug and device studies may follow applicable FDA and research oversight requirements.
Institutional review boards help evaluate participant protections and informed consent materials.
The study team should explain how personal and health information is collected, used, and protected.
You can ask questions, review consent materials, and decide whether participation is right for you.
Contact All Seniors Foundation to ask whether screening is available and what questions to prepare before speaking with the study team.
(818) 581-4101
Available 8 AM - 6 PM, Mon-Sun
16101 Ventura Blvd Suite 300
Encino, CA 91436
